Learn more about research in the Division of Endocrinology and Metabolism.
Endocrinology and Metabolism
| Faculty Member | Division | Research Expertise |
|---|---|---|
| Sanford Baim, MD | Endocrinology and Metabolism | |
| David Baldwin, MD | Endocrinology and Metabolism |
PERL study completed Fall 2015, NIH sponsored trial of therapy for diabetic nephropathy. Inpatient/outpatient Linagliptin study (Emory University), final subject was enrolled 10 days ago, outpatient follow up through Feb 2016, then study is complete. Trial of linagliptin vs basal-bolus insulin for inpatient diabetes followed by 3 month outpatient extension. More billing needs to be done. LEADER study is in the final stages of completion, data clean-up, queries etc. Five year cardiovascular safety study for liraglutide therapy of type 2 diabetes at high risk for developing CV complications. More billing needs to be done. |
| Antonio Bianco, MD | Endocrinology and Metabolism | McAninch, Werneck de Castro and Bianco study the role of the deiodinases in health and disease states with emphasis on thyroid hormone signaling and hypothyroidism. Visit the Bianco Lab website for more information on research under way. |
| Brian Kim, MD | Endocrinology and Metabolism | |
| Elizabeth McAninch, MD | Endocrinology and Metabolism | Learn more |
| Mahtab Sohrevardi, MD | Endocrinology and Metabolism | |
| Kristina Todorova-Koteva, MD | Endocrinology and Metabolism | |
| Joa Pedro Werneck DeCastro, PhD | Endocrinology and Metabolism | McAninch, Werneck de Castro and Bianco study the role of the deiodinases in health and disease states with emphasis on thyroid hormone signaling and hypothyroidism. |